Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11466262 Methods and systems for purifying non-complexed

Patent 11466262 was granted and assigned to Revance Therapeutics, Inc. on October, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Revance Therapeutics, Inc.

Current Assignee

‌

Revance Therapeutics, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114662620

Patent Inventor Names

Curtis L. Ruegg0

Date of Patent

October 11, 2022

Patent Application Number

167007280

Date Filed

December 2, 2019

Patent Citations

‌

US Patent 10465178 Process and system for obtaining botulinum neurotoxin

‌

US Patent 10111939 Albumin-free botulinum toxin formulations

‌

US Patent 10201594 Compositions and methods for safe treatment of rhinitis

‌

US Patent 10307468 Manufacture of di-chain recombinant

‌

US Patent 10619143 Method and producing botulinum toxin

Patent Primary Examiner

‌

Nita M. Minnifield

Methods and systems for chromatographically purifying a

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11466262 Methods and systems for purifying non-complexed

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API